Vivek Das: How Obesity, Type 2 Diabetes, and Dyslipidaemia Interact Across Multiple Cardiovascular Conditions
Vivek Das, Lead Data Scientist at Novo Nordisk, shared a post on LinkedIn about a recent article by Paul C Evans, published in European Heart Journal, adding:
“A noticeable shift in cardiometabolic research is the move from isolated risk factors toward a more integrated, mechanism – driven view of disease.
Recent work highlights how obesity, type 2 diabetes, and dyslipidaemia interact across multiple cardiovascular conditions, rather than acting independently.
As biology becomes more interconnected, it reshapes how patients are stratified, how endpoints are defined, and how evidence is generated across the lifecycle.
For complex chronic diseases, the challenge is no longer identifying signals, but translating interconnected biology into coherent evidence that can inform decisions at scale.”
Title: Novel cardiovascular metabolic risk factor mechanisms and therapeutic opportunities: A scientific statement of the ESC Council on Basic Cardiovascular Science, the ESC Working Group on Atherosclerosis and Vascular Biology, the ESC Working Group on Cellular Biology of the Heart, the ESC Working Group on Myocardial Function, and the ESC Working Group on Cardiac Cellular Electrophysiology
Authors: Paul C Evans, Gemma Vilahur, Petra Kleinbongard, Elena Osto, Carol Ann Remme, Rosalinda Madonna, Dunja Aksentijevic, Harald Sourij, Sean M Davidson, Donato Santovito, Jürgen Gindlhuber, Christian Weber, Wolfgang A Linke, Esther Lutgens, Luc Bertrand, Dana Dawson, Magnus Bäck, G Danilo Norata, Johann Wojta, Cinzia Perrino
Read the Full Article on European Heart Journal
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 7, 2026, 23:20Balaji Balagani: Exploring Pulmonary Embolism
-
Jul 7, 2026, 23:03Roxana González Mazarío: The Phenotype-Specific Cardiovascular Risks in AAV
-
Jul 7, 2026, 22:52Harry Spoelstra: LongC0VID Still has Zero Proven Treatments
-
Jul 7, 2026, 22:39Satya K. Morar: Acute Portal Vein Thrombosis as an Exceptionally Rare Complication of Liver Biopsy in CVID
-
Jul 7, 2026, 22:23Aravind Palraj: Antiphospholipid Syndrome is not Just ‘Start Warfarin and Follow INR’
-
Jul 7, 2026, 20:59William Aird: An Unlucky Turn Into the Renal Artery
-
Jul 7, 2026, 20:58Chokri Ben Lamine: The Two-Hit Model of TRALI
-
Jul 7, 2026, 20:57New Issue of Blood Out Now – Blood Journals Portfolio
-
Jul 7, 2026, 20:56Priyadarshini Ramakrishnan: Schistocytes – The Most “Misleading Heroes” in a Peripheral Smear